Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Current Deferred Revenue: 2020-2024

Historic Current Deferred Revenue for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Dec 2024 value amounting to $3.3 million.

  • Maravai Lifesciences Holdings' Current Deferred Revenue rose 21.16% to $2.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.6 million, marking a year-over-year increase of 21.16%. This contributed to the annual value of $3.3 million for FY2024, which is 40.00% down from last year.
  • According to the latest figures from FY2024, Maravai Lifesciences Holdings' Current Deferred Revenue is $3.3 million, which was down 40.00% from $5.5 million recorded in FY2023.
  • Over the past 5 years, Maravai Lifesciences Holdings' Current Deferred Revenue peaked at $79.2 million during FY2020, and registered a low of $3.3 million during FY2024.
  • For the 3-year period, Maravai Lifesciences Holdings' Current Deferred Revenue averaged around $4.5 million, with its median value being $4.8 million (2022).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Current Deferred Revenue crashed by 84.09% in 2021, and later rose by 14.58% in 2023.
  • Maravai Lifesciences Holdings' Current Deferred Revenue (Yearly) stood at $79.2 million in 2020, then crashed by 84.09% to $12.6 million in 2021, then crashed by 61.90% to $4.8 million in 2022, then climbed by 14.58% to $5.5 million in 2023, then slumped by 40.00% to $3.3 million in 2024.